Panama's First Ever Global Medical #Cannabis Summit Panama City, February 13-14, 2019
Int'l Industry Leaders in Business, Medical Science & Technology to Gather at CannaTech Panama
Tel Aviv, Israel - December 19, 2018 (Investorideas.com Newswire) As the global medical cannabis market continues to expand exponentially and increasing numbers of countries around the globe legalize its use, including in Latin America, Panama's first ever Medical Cannabis Summit will take place in Panama City, October February 13-14, 2018 at the Central Hotel in Casco Viejo, the capital's unique Old Quarter which is UNESCO World Heritage Site.
CannaTech Panama will bring together industry leaders from Latin America and around the world known for their significant and ground-breaking contributions to the global medical cannabis market in all fields.
The Summit will cover the most current industry topics including Agricultural Tech and Innovation, Business and Finance, Policy and Regulation, Science and Medicine.
Click here for a preliminary list of CannaTech Panama speakers.
"Latin America is a key and growing player in the exploding cannabis field. Medical cannabis is legal in 9 Latin American countries and that list is fast growing. According to the research consultancy Prohibition Partners, it's estimated that the region's cannabis market will be worth $12.7 billion in 2028 while the medical cannabis market is forecast to be worth $8.5 billion within the decade. We are thrilled to bring some of the world's leading companies and investors to Panama to meet with their counterparts to discuss a range of business and technological issues. I could not be prouder to bring CannaTech to Panama and work with like minded professionals who understand the immense global health and business potential of medical cannabis moving forward," said Saul Kaye, Founder and CEO of iCAN:Israel-Cannabis.
About CannaTech
CannTech is the only Medical Cannabis event of its kind with a global focus that offers senior industry leaders, medical and scientific experts, and new ventures the platform to come together, drive innovation, form partnerships and promote knowledge exchange.
About iCAN: Israel-Cannabis
iCAN: Israel-Cannabis is a leading Israeli developer of cannabis-based formulations, clinical trials and cannabis testing. iCAN is committed to accelerate Israel's Canna-Technology industry, capitalizing on Israeli innovation and a leading cannabis regulatory environment to bring premier products to market. iCAN is powered by CannaTech, the premier international cannabis summit held annually in Tel Aviv, London, Sydney and now Panama.
For further information, media inquiries and journalist registration contact:
Laura Kam, laura@kamgs.com, +972-54-806-8613.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
